World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 48

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2509)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series.

Item

Count

PDF

341

HTML

2062

Figures (1-1)

106

Sum=2509

Dec 28, 2005 (publication date) through Apr 24, 2024

Times Cited of This Article

Times Cited (16)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Dohmen K, Wen CY, Nagaoka S, Yano K, Abiru S, Ueki T, Komori A, Daikoku M, Yatsuhashi H, Ishibashi H. Fenofibrate-induced liver injury. World J Gastroenterol 2005; 11(48): 7702-7703 [PMID: 16437706 DOI: 10.3748/wjg.v11.i48.7702]
URL:	https://www.wjgnet.com/1007-9327/full/v11/i48/7702.htm

Number	Citing Articles
1	Maxwell Afari Gyamfi, Yu-Jui Yvonne Wan. Mechanisms of Resistance of Hepatocyte Retinoid X Receptor α-Null Mice to WY-14,643-induced Hepatocyte Proliferation and Cholestasis. Journal of Biological Chemistry 2009; 284(14): 9321 doi: 10.1074/jbc.M808861200
2	Maxwell Afari Gyamfi, Yu-Jui Yvonne Wan. Pathogenesis of alcoholic liver disease: the role of nuclear receptors. Experimental Biology and Medicine 2010; 235(5): 547 doi: 10.1258/ebm.2009.009249
3	Takako Yokozawa, Chan Hum Park, Jeong Sook Noh, Takashi Tanaka, Eun Ju Cho. Novel action of 7-O-galloyl-d-sedoheptulose isolated from Corni Fructus as a hypertriglyceridaemic agent. Journal of Pharmacy and Pharmacology 2010; 61(5): 653 doi: 10.1211/jpp.61.05.0015
4	Maka S. Hedrington, Stephen N. Davis. Peroxisome proliferator-activated receptor alpha-mediated drug toxicity in the liver. Expert Opinion on Drug Metabolism & Toxicology 2018; 14(7): 671 doi: 10.1080/17425255.2018.1483337
5	Hye Young Lee, Ae-Ra Lee, Jeong-Ju Yoo, Susie Chin, Sang Gyune Kim, Young Seok Kim. Biopsy-confirmed fenofibrate-induced severe jaundice: A case report. World Journal of Clinical Cases 2021; 9(30): 9295-9301 doi: 10.12998/wjcc.v9.i30.9295 Abstract(470) \| Core Tip(371) \| Full Article(HTML)(1581) \| Full Article (PDF)-4721K(250) \| Full Article (Word)-1374K(91) \| Audio-403K(3) \| Peer-Review Report-170K(59) \| Answering Reviewers-673K(54) \| Times Cited (3) \| Total Visits (5158) \| Open
6	Xiaoyin Ye, Tong Zhang, Han Han. PPARα: A potential therapeutic target of cholestasis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.916866
7	Xue-Mei Gu, Chao-Yin Lu, Jian Pan, Jian-Zhong Ye, Qi-Han Zhu. Alteration of intestinal microbiota is associated with diabetic retinopathy and its severity: Samples collected from southeast coast Chinese. World Journal of Diabetes 2023; 14(6): 862-882 doi: 10.4239/wjd.v14.i6.862 Abstract(375) \| Core Tip(201) \| Full Article(HTML)(1308) \| Full Article with Cover (PDF)-3637K(25) \| Full Article (Word)-2076K(17) \| Audio-591K(0) \| Peer-Review Report-203K(21) \| Answering Reviewers-143K(22) \| Full Article (PDF)-3432K(108) \| Full Article (XML)-207K(21) \| Times Cited (2) \| Total Visits (3455) \| Open
8	Shizhan Ma, Shudong Liu, Qi Wang, Lijuan Chen, Ping Yang, Huihuan Sun. Fenofibrate‐induced hepatotoxicity: A case with a special feature that is different from those in the LiverTox database. Journal of Clinical Pharmacy and Therapeutics 2020; 45(1): 204 doi: 10.1111/jcpt.13042
9	Dina Halegoua-De Marzio, Victor J. Navarro. Drug-Induced Liver Disease. 2013; : 519 doi: 10.1016/B978-0-12-387817-5.00029-7
10	Vinod S. Hegade, Amardeep Khanna, Lucy J. Walker, Lin-Lee Wong, Jessica K. Dyson, David E. J. Jones. Long-Term Fenofibrate Treatment in Primary Biliary Cholangitis Improves Biochemistry but Not the UK-PBC Risk Score. Digestive Diseases and Sciences 2016; 61(10): 3037 doi: 10.1007/s10620-016-4250-y
11	Jawad Ahmad, Joseph A. Odin, Paul H. Hayashi, Naga Chalasani, Robert J. Fontana, Huiman Barnhart, Elizabeth T. Cirulli, David E. Kleiner, Jay H. Hoofnagle. Identification and Characterization of Fenofibrate-Induced Liver Injury. Digestive Diseases and Sciences 2017; 62(12): 3596 doi: 10.1007/s10620-017-4812-7
12	Ying-Jung Hsu, Lu-Chun Wang, Wei-Shiung Yang, Chung-May Yang, Chang-Hao Yang. Effects of Fenofibrate on Adiponectin Expression in Retinas of Streptozotocin-Induced Diabetic Rats. Journal of Diabetes Research 2014; 2014: 1 doi: 10.1155/2014/540326
13	Ju-Yang Jung, Young Choi, Chang-Hee Suh, Dukyong Yoon, Hyoun-Ah Kim. Effect of fenofibrate on uric acid level in patients with gout. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-35175-z
14	Azza A. K. El-Sheikh, Rehab A. Rifaai. Peroxisome Proliferator Activator Receptor (PPAR)-γLigand, but Not PPAR-α, Ameliorates Cyclophosphamide-Induced Oxidative Stress and Inflammation in Rat Liver. PPAR Research 2014; 2014: 1 doi: 10.1155/2014/626319
15	Takeshi Okanoue, Atsushi Umemura, Kohichiroh Yasui, Yoshito Itoh. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in Japan. Journal of Gastroenterology and Hepatology 2011; 26(s1): 153 doi: 10.1111/j.1440-1746.2010.06547.x
16	D. Hajdu, K. Aiglová, I. Vinklerová, K. Urbánek. Acute cholestatic hepatitis induced by fenofibrate. Journal of Clinical Pharmacy and Therapeutics 2009; 34(5): 599 doi: 10.1111/j.1365-2710.2009.01029.x